MMR (live attenuated) dosing and route
Give 0.5 mL per dose subcutaneously; routine schedule is 2 doses at 12–15 months and 4–6 years, with doses ≥28 days apart if accelerated. 1, 2, 3
Product/route
Dose
- Single dose ≈ 0.5 mL. 1
Routine schedule (prioritizes morbidity, mortality, QoL by ensuring immunity)
Special situations (to reduce severe outcomes/outbreak risk)
Administration/handling pitfalls to avoid
- Reconstitute with supplied diluent; protect from light; use within 8 hours if refrigerated (2–8°C); discard if discolored/particulate. 1
- Do not coadminister immune globulins or blood products concurrently; separate live vaccines not given same day by ≥4 weeks. 1, 2, 3
- Contraindications: pregnancy, severe immunosuppression, severe allergy to components (e.g., gelatin, neomycin). 1